4//SEC Filing
T2 Biosystems, Inc. 4
Accession 0001104659-17-008626
CIK 0001492674operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:42 PM ET
Size
7.5 KB
Accession
0001104659-17-008626
Insider Transaction Report
Form 4
Harding David
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2017-02-09+17,500→ 17,500 total→ Common Stock (17,500 underlying) - Award
Stock Option (Right to Buy)
2017-02-09+35,000→ 35,000 totalExercise: $5.67Exp: 2027-02-08→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units vest in three equal annual installments beginning on February 9, 2018.
- [F3]The stock option vests in 48 monthly installments commencing February 9, 2017.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492674
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:42 PM ET
- Size
- 7.5 KB